Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon.

Article English OPEN
Cunha, SS; Rodrigues, LC; Pedrosa, V; Dourado, IM; Barreto, ML; Pereira, SM;
(2004)
  • Publisher: British Leprosy Relief Assoc

: There is clear evidence that BCG protects against leprosy, but cross-immunity with environmental mycobacteria can interfere with vaccination protection. Some have cast doubts whether BCG vaccination can offer a significant impact against leprosy in the Brazilian Amazo... View more
  • References (28)
    28 references, page 1 of 3

    1 Fine PE. Primary prevention of leprosy. Int J Lepr Other Mycobact Dis, 1996; 64: S44- 49.

    2 Lombardi C, Pedrazzani ES, Pedrazzani JC et al. Protective efficacy of BCG against leprosy in Sao Paulo. Bull Pan Am Health Org, 1996; 30: 24 - 30.

    3 Fine PE. The Kellersberger memorial lecture. The role of BCG in the control of leprosy. Ethiop Med J, 1985; 23: 179- 191.

    4 Stanford JL, Shield MJ, Rook GA. How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle, 1981; 62: 55 - 62.

    5 World Health Organisation. Leprosy - global situation. Weekly Epidemiol Rec, 2000; 75: 226- 231.

    6 Ministe´rio da Sau´deHanseniase. Vigilaˆncia Epidemiolo´gica de Doenc¸as e Agravos Espec´ıficos. Source: http:// www.funasa.gov.br/pub/GVE/GVE0513A.htm. Accessed on 20th July 2001.

    7 Salem JI, Gontijo Filho P, Levy Frebault V, David HL. Isolation and characterization of mycobacteria colonizing the healthy skin. Acta Leprol, 1989; 7 (suppl): 18 - 20.

    8 David HL, Papa F, Cruaud P et al. Relationships between titers of antibodies immunoreacting against glycolipid antigens from Mycobacterium leprae and M. tuberculosis, the Mitsuda and Mantoux reactions, and bacteriological loads: implications in the pathogenesis, epidemiology and serodiagnosis of leprosy and tuberculosis. Int J Lepr Other Mycobact Dis, 1992; 60: 208 - 224.

    9 Salem JI, Cruaud P, David HL. Does previous BCG vaccination interfere with the serodiagnosis of tuberculosis using Mycobacterium tuberculosis-specific glycolipid antigens?. Int J Lepr Other Mycobact Dis, 1992; 60: 87 - 89.

    10 Barreto ML, Rodrigues LC, Cunha SS et al. Design of the Brazilian BCG-REVAC trial against tuberculosis: a large, simple randomised community trial to evaluate the impact on tuberculosis of BCG revaccination at school age. Control Clin Trials, 2002; 23: 540- 553.

  • Related Organizations (4)
  • Metrics
Share - Bookmark